Overview

BVAIT: B-Vitamin Atherosclerosis Intervention Trial

Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine whether vitamin B supplementation will reduce the progression of early atherosclerosis in individuals over 40 years old and without clinical evidence of cardiovascular disease (CVD).
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
National Institute on Aging (NIA)
Collaborator:
Leiner Health Products
Treatments:
Folic Acid
Hydroxocobalamin
Pyridoxal
Pyridoxine
Vitamin B 12
Vitamin B 6
Vitamin B Complex
Vitamins